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The aim of the present study was to determine the ventilation/perfusion
ratio that contributes to hypoxemia in pulmonary embolism by analyz-
ing blood gases and volumetric capnography in a model of experimental
acute pulmonary embolism. Pulmonary embolization with autologous
blood clots was induced in seven pigs weighing 24.00 ± 0.6 kg,
anesthetized and mechanically ventilated. Significant changes occurred
from baseline to 20 min after embolization, such as reduction in oxygen
partial pressures in arterial blood (from 87.71 ± 8.64 to 39.14 ± 6.77
mmHg) and alveolar air (from 92.97 ± 2.14 to 63.91 ± 8.27 mmHg). The
effective alveolar ventilation exhibited a significant reduction (from
199.62 ± 42.01 to 84.34 ± 44.13 mL) consistent with the fall in alveolar
gas volume that effectively participated in gas exchange. The relation
between the alveolar ventilation that effectively participated in gas
exchange and cardiac output (VAeff/Q ratio) also presented a significant
reduction after embolization (from 0.96 ± 0.34 to 0.33 ± 0.17 fraction).
The carbon dioxide partial pressure increased significantly in arterial
blood (from 37.51 ± 1.71 to 60.76 ± 6.62 mmHg), but decreased
significantly in exhaled air at the end of the respiratory cycle (from 35.57
± 1.22 to 23.15 ± 8.24 mmHg). Exhaled air at the end of the respiratory
cycle returned to baseline values 40 min after embolism. The arterial to
alveolar carbon dioxide gradient increased significantly (from 1.94 ±
1.36 to 37.61 ± 12.79 mmHg), as also did the calculated alveolar (from
56.38 ± 22.47 to 178.09 ± 37.46 mL) and physiological (from 0.37 ±
0.05 to 0.75 ± 0.10 fraction) dead spaces. Based on our data, we conclude
that the severe arterial hypoxemia observed in this experimental model
may be attributed to the reduction of the VAeff/Q ratio. We were also able
to demonstrate that VAeff/Q progressively improves after embolization,
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Introduction
Hypoxemia is one of the most important
clinical signs of pulmonary embolism (PE).
The complex abnormalities in gas exchange
that occur are multiple, but the literature
remains unassertive to elucidate the underly-
ing mechanisms (1-10).
Analysis of the mechanisms involved in
the genesis of this severe hypoxemia in hu-
mans with PE is difficult because of the
multiple variables associated, including car-
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diopulmonary disease (8,9). Dantzker and
Bower (8) stated that this difficulty exists
even in experimental situations because of
differences in species, the specific experi-
mental circumstances, as well as the size,
composition and quantity of the embolized
material utilized, which may influence re-
sults in each individual model (11).
Several mechanisms are believed to be
responsible for hypoxemia. These include
low-partial oxygen pressure in mixed venous
blood (PvO2), the mismatch between ventila-
tion and perfusion, the intrapulmonary shunt,
the diffusion limitation, and the severity of
the embolism, impairing the identification of
the real cause of hypoxemia (8,9). Recently,
the mechanisms responsible for gas exchange
have been investigated with the use of the
multiple inert gas elimination technique (9).
In normal lungs there is equilibrium be-
tween alveolar ventilation and capillary per-
fusion at the proportion of approximately
1:1. The transfer of O2 is jeopardized when
this equilibrium is altered and this propor-
tion is reduced (2,4).
Pulmonary shunt occurs in humans and
animals after PE, although its etiology has
not been clearly established (8). Kasinski et
al. (7) did not find a significant shunt in the
embolization of the pulmonary circulation
of dogs with autologous clots. Similarly,
Wilson et al. (12) did not detect a shunt in
clinical studies.
Mismatch between ventilation and per-
fusion has been reported by most investiga-
tors as the most common cause of the gene-
sis of hypoxemia in PE. Correction of mis-
matching alveolar ventilation to cardiac out-
put (CO) ratio (VA/Q) may occur from the
redistribution of the perfusion towards ven-
tilated areas or from a fall in ventilation of
areas with limited or absent perfusion (3-
6,8,10,13,14). Indeed, Levy and Simmons
(15) observed that in PE there is a partial
auto-regulation of the alveolar ventilation
and perfusion at the lobar and segmental
levels in order to maintain the equilibrium of
the VA/Q (4,16). This phenomenon has only
recently been confirmed with technology
based on positron emission tomography scan
that quantifies the redirection of the ventila-
tion to alveoli with maintained perfusion,
called effective or regional alveolar ventila-
tion (VAeff) (14,17,18). Most studies attribute
the redirection of alveolar ventilation to re-
gional bronchoconstriction induced by al-
veolar hypocapnia (14,15,17,19,20). How-
ever, this redistribution of alveolar ventila-
tion varying from nonexistent to highly sig-
nificant has been frequently reported in the
literature (8,9,15), probably because of the
different approaches and models used (3).
A third element described in the patho-
genesis of hypoxemia in PE is the reduction
in PVO2 as a result of the fall in CO (8).
The aim of the present study was to de-
termine the effective alveolar ventilation to
perfusion ratio as a possible causal factor of
hypoxemia in an experimental acute model
of PE.
Material and Methods
The study was conducted in the Núcleo
de Medicina e Cirurgia Experimental of the
State University of Campinas (UNICAMP)
and was approved by the Ethics Committee
for Animal Research of the Institute of Biol-
ogy, UNICAMP.
Seven Large-White pigs weighing 24.00
± 0.6 kg were pretreated with 10 mg/kg
intramuscular ketamine and subsequently
anesthetized with 12 µg/kg fentanyl citrate
and 25 mg/kg sodium thiopentate.
The animals were intubated and con-
nected to a Servo 900B mechanical ventila-
tor in a volume-controlled mode, with in-
spired oxygen fraction of 0.21 and minute
volume and respiratory rate adjusted to main-
tain a carbon dioxide partial pressure in arte-
rial blood (PaCO2) of about 40 mmHg. The
tidal volume (VT) was approximately 350
mL and the positive pressure at the end of
exhalation was adjusted to 5 cmH2O with
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decreasing inspiratory air flow.
A #5F-Swan-Ganz pulmonary artery cath-
eter was introduced through the right femoral
vein. A #6F-polyethylene catheter was intro-
duced through the femoral artery and the tip
was guided to the abdominal aorta. The cor-
rect location of the catheters was checked
systematically by the analysis of the morphol-
ogy of the pressure curves. Each catheter was
filled with saline solution containing 5 units of
heparin/mL and was connected to a Medex
electromanometer (Hilliard, OH, USA). CO
and blood pressure were recorded with a car-
diac monitor (BESE, Belo Horizonte, MG,
Brazil). All pressures were measured with the
animals in the supine position and the zero
reference point was set at the mid-thoracic line
of the animal.
The blood pressure monitor was cali-
brated with a standard mercury column and
CO was obtained by thermodilution, with
the injection of 5% dextrose in water at a
temperature of less than 5ºC.
The central temperature was obtained
directly from the thermistor located at the tip
of the pulmonary artery. Blood samples were
collected simultaneously from the arterial
and mixed venous lines and immediately
analyzed with an IL-640 instrument (Instru-
mentation Laboratory, Lexington, MA,
USA). Blood lactate was measured with an
equipment that provides lactate values within
1 min from a single drop of arterial blood
(Accusport, Boehringer Mannheim, Asta
Medica, São Paulo, SP, Brazil).
The following hemodynamic parameters
were measured and their variables calcu-
lated: CO, mean arterial pressure (MAP),
pulmonary artery pressure (PAP), occluded
pulmonary artery pressure, and heart rate.
Capnography was carried out using the res-
piratory profile monitor DX-8100 (CO2
SMOPlus, Novametrix/Respironics, Che-
shire, CT, USA). Analysis Plus software
(Novametrix/Respironics) was used for the
calculation of the physiological respiratory
variables. The CO2SMOPlus pneumotacho-
graph is based on the principle of differential
manometry with a fixed resistance and is
auto-calibrated.
One hour before embolization, 100 IU
lyophilized bovine thrombin (Laboratory
Instrumentation Company, Lexington, MA,
USA) were added to 200 mL of blood re-
moved from the jugular vein. After a period
of 45 min the clotted blood was fragmented
with a manual processor in order to obtain
uniform fragments of clots measuring ap-
proximately 3 mm in diameter. These thrombi
were filtered and suspended in saline solu-
tion and placed in a large syringe connected
to a #14F-polyethylene catheter inserted into
the left jugular vein of the animal.
The clots were injected in small volumes
in order to reach the end point of a mean PAP
(MPAP) two and a half times the MPAP
recorded before embolism. The total volume
of injected clots was 24.66 ± 4.27 mL and
the average total time of clot injection was
20 min. Recordings of hemodynamic, cap-
nographic, arterial and mixed venous blood
gases, and blood lactate were carried out
before embolization (baseline) and every 20
min starting at the end of clot injection. Four
recordings were obtained, T0 (baseline) and
T20, T40, and T60, at 20, 40, and 60 min,
respectively, after MPAP established as the
end point of embolization.
The Fowler method was used by the
CO2SMOPlus to calculate the anatomical
dead space (VDana). The physiological dead
space (VD/VTphys) was calculated with the
equation of Bohr-Enghoff (21):
VD/VTphys = (PaCO2 - PECO2)/PaCO2
where PECO2 is the partial pressure of mean
CO2 in exhaled air.
The alveolar dead space (VDalv) was cal-
culated as the difference between the physi-
ological dead volume (VDphys, Bohr-Eng-
hoff) (21) and the VDana.
VDalv = VDphys - VDana
Tidal alveolar volume (VTalv) was cal-
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The partial pressure of oxygen in alveo-
lar air (PAO2) was calculated from the equa-
tion of the alveolar air (22) with the formula:
 PAO2 = PIO2 - (PaCO2/QR)
where PIO2 is the partial oxygen pressure on
inspired air, PaCO2 was obtained from blood
gas report and QR is the respiratory quotient
considered to be fixed and equal to 0.8.
Systemic vascular resistance (SVR) was
calculated by the equation SVR = MAP/CO
and pulmonary vascular resistance (PVR) was
calculated by the equation PVR = MPAP/CO.
Statistical analysis
Analysis of variance (ANOVA) for re-
peated measures with rank was used to com-
pare the variables of interest for each group
and for each time, with the level of signifi-
cance set at 5% (P < 0.05).
Results
After embolization there was a signifi-
cant fall in oxygen partial pressure in arterial
blood (PaO2), PVO2 and PAO2, as shown in
Figure 1.
Alveolar to arterial oxygen partial pres-
sure gradient (P(A-a)O2) increased at T20
after embolization. However, it fell again at
T60. Figure 2 shows a significant increase of
PaCO2 and carbon dioxide partial pressure
in mixed venous blood 20 min after embo-
lism. Exhaled air at the end of the respiratory
cycle (PetCO2) was significantly reduced at
this time, returning to baseline at T40 (Figure
2). However, the arterial to alveolar carbon
dioxide gradient (P(a-et)CO2) increased sig-
nificantly and remained elevated up to T60.
Figure 3 shows increases of VDalv and
VDphys. VDana did not change. The VTalv
remained unchanged throughout the experi-
ment. On the other hand, at T20, VAeff exhib-
ited a significant reduction despite a fixed
minute volume, followed by a tendency to
recovery.
Figure 1. Partial pressure of oxy-
gen in alveolar air (PAO2), in ar-
terial blood (PaO2) and in
venous blood (PvO2) during ex-
perimental pulmonary embolism
(PE) in pigs. Data are reported
as means ± SD for 7 pigs.
Figure 2. Carbon dioxide par-
tial pressure in arterial blood
(PaCO2) and in venous blood
(PvCO2), and end tidal exhaled
air (PetCO2) during experimen-
tal pulmonary embolism (PE) in
pigs. Data are reported as means
± SD for 7 pigs.
Figure 3. Respiratory variation
in volume per breath during ex-
perimental pulmonary embolism
(PE) in pigs. Data are reported
as means for 7 pigs. VT = tidal
volume; VDphys = physiological
dead space.
culated as the simple difference between the
VT and the VDphys.
VTalv = VT - VDphys
The VAeff was calculated as the simple
difference between the VTalv and the VDphys.
VAeff = VTalv - VDphys
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The VAeff/Q ratio exhibited a significant
reduction at T20 after embolization (Figure
4). However, at T40 and T60 these values
tended to recover partially.
MPAP starting from a mean baseline
value of 15.57 ± 2.23 mmHg reached a mean
value of 46.71 ± 3.90 mmHg after emboliza-
tion (T20), with no changes in CO. On the
other hand, all animals presented severe
tachycardia at T20. However, mean blood
pressure did not change after embolization.
Pulmonary vascular resistance increased sig-
nificantly at T20, remaining elevated at T40
and T60 (Figure 5).
Discussion
Blockade of pulmonary perfusion by clots
results in ventilation of non-perfused alveoli,
characterizing wasted ventilation, conven-
tionally named VDalv. The increase in VDalv
subtracts a considerable fraction of alveolar
ventilation, leading to reduction of VAeff
(15).
The present data show that VDana was
unchanged, whereas VDphys and VDalv in-
creased in an expressive way as a result of
blood clots impairing the pulmonary circu-
lation of the animals (2,13).
Since no increase in VDana was detected,
the expressive increase in VDphys could be
exclusively attributed to the increase in
VDalv. The significant increase in PaCO2
after embolization was attributed to the abol-
ished reflex hyperventilation normally trig-
gered by hypercapnia, because the animals
were sedated and mechanically ventilated
(2,15).
It could be argued that the reduction of
VDalv, the P(a-et)CO2 gradient and the im-
provement of VAeff and arterial oxygen-
ation at T40 and T60 were caused by sponta-
neous thrombolysis. If this was the case, a
reduction in pulmonary vascular resistance
should be expected. Actually, pulmonary
vascular resistance increased at T20 and re-
mained elevated at T40 and T60 (Figure 5).
Figure 4. Effective alveolar ventilation per breath (VAeff) and effective alveolar ventilation
to cardiac output ratio (VAeff/Q) during experimental pulmonary embolism (PE) in pigs.
Data are reported as means ± SD for 7 pigs.
Figure 5. Pulmonary vascular resistance (PVR) and mean pulmonary artery pressure
(MPAP) during experimental pulmonary embolism (PE) in pigs. Data are reported as means
± SD for 7 pigs
This fact can only be attributed to vasocon-
striction induced by the low PAO2 values
(Figure 1) since it has been shown that PAO2
values below 70 mmHg trigger marked va-
soconstriction, up to the point where blood
flow is abolished (8,15,23,24).
On the other hand, the reduction of
PetCO2 was reversed at T40. This behavior
was interpreted as redistribution of alveolar
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ventilation and as relative reperfusion of the
vascular bed due to the reduction of VDalv at
T40 (Figure 2) despite elevated values com-
pared to baseline.
In a study of the kinetics of carbon diox-
ide pulmonary artery occlusion in dogs with
subsequent reperfusion, Anderson and Breen
(13) stated that the return of PetCO2 to base-
line values is indicative of pulmonary perfu-
sion and, indeed, in the present study PetCO2
returned to baseline levels at T40 (Figure 2).
However, this finding cannot be attributed
exclusively to thrombolysis since PaO2 and
PaCO2 did not normalize.
As can be seen in Figure 1, the animals
presented an important fall in PAO2 and PaO2
which was much more pronounced than ex-
pected, causing only an increase in alveolar
carbon dioxide. For this reason, a second
mechanism must be responsible for the im-
portant hypoxemia observed, such as pul-
monary shunt or mismatch between ventila-
tion and perfusion (23).
Venous admixture (Qva/Qt) increased
significantly. However, this variable does
not discriminate venous mixture from true
shunt. Despite suggestions that alterations in
surfactant synthesis due to pulmonary em-
bolism can induce alveolar collapse (8,25),
it is hard to believe that these alterations
would occur as early as 20 min after PE.
Also, the true shunt could hardly be attrib-
uted to alveolar exclusion as observed in
acute respiratory distress syndrome or in
acute pulmonary edema. For these reasons,
it is more sensible to attribute the increase of
the Qva/Qt ratio to a VA/Q imbalance.
In this model of PE, redistribution of
perfusion must have necessarily occurred
since there were non-perfused areas in the
pulmonary circulation and CO was un-
changed.
In this experimental model, the venti-
lated, but non-perfused alveoli increased
VDalv from 56.38 ± 22.47 at baseline to
178.09 ± 37.46 mL at T20. Actually, the
increase in dead space per se does not induce
hypoxemia. For this reason, hypoxemia is
attributed to a significant alteration of the
VA/Q ratio (3,5,10,14,15,17,25), with alveo-
lar ventilation being slightly increased but
with perfusion being markedly increased.
The effective alveolar ventilation is de-
fined as the ventilation in contact with the
pulmonary circulation (26). Although the
term “effective alveolar ventilation” is not
currently used in respiratory physiology text-
books, Levy and Simmons (15), in 1974,
introduced this term to characterize exclu-
sively the ventilation of areas with main-
tained or increased perfusion. The increase
in VAeff with time (Figures 3 and 4) was
attributed to hypocapnic bronchoconstriction
because the authors showed that a group of
animals that inhaled 3% CO2 after pulmo-
nary embolism did not exhibit the expected
increase in VAeff (15).
In the present study, the VTalv remained
unchanged because the animals were on
mechanical ventilation with a fixed minute
volume. The non-perfused pulmonary areas
were not anatomically quantified after em-
bolization. However, in the sequential evalu-
ation, a significant increase in VAeff at T40
and T60 was observed when compared to the
VAeff at T20 after embolism. This evidence
suggests that the mechanism of hypocapnic
bronchoconstriction did occur and that the
alveolar ventilation was effectively redirected
to units of effective gas exchange. This re-
covery of VAeff was associated with a sig-
nificant improvement in the VAeff/Q ratio as
well as arterial oxygenation at T40 and T60
(Figures 1 and 4). The fall in the P(A-a)O2 at
T40 and T60 corroborates the increase in VAeff
and VAeff/Q induced by redirection of venti-
lation. Similarly, the normalization of PetCO2
as early as 40 min after embolization ex-
presses the redirectioning of alveolar venti-
lation by the hypocapnic alveolar broncho-
constriction (Figure 2). However, the in-
crease in P(a-et)CO2 (Figure 2) is essentially
attributed to the persistent elevation of PaCO2
induced by a fixed minute volume.
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Vidal Melo et al. (14), after injecting
autologous clots in six mechanically venti-
lated sheep, confirmed by positron emission
tomography scan that there was an increase
in regional alveolar ventilation in pulmo-
nary areas that remained perfused after em-
bolization, as an expression of the redistri-
bution of VT mediated by the hypocapnic
bronchoconstriction. The quantity and qual-
ity of the clots used in the experimental
studies may influence the duration and in-
tensity of bronchoconstriction. Fresh clots
may liberate serotonin because of the pres-
ence of thrombin. Robinson et al. (27) showed
that serotonin has an important bronchocon-
strictor effect when pulmonary emboliza-
tion is induced with fresh clots. Levy and
Simmons (15) observed a bronchoconstric-
tion of 30-min duration after injection of 30
mL of fresh clots. In our study, bronchocon-
striction occurred up to 60 min after embo-
lization, as suggested by the progressive
increase in effective alveolar ventilation. This
finding is attributed to the large quantity of
clots (24.66 ± 4.27 mL) and to the added
lyophilized bovine thrombin.
In the present study, VDalv as well as
P(a-et)CO2 increased significantly at T20
(56.38 ± 22.47 to 178.09 ± 37.46 mL, and
1.94 ± 1.36 to 37.61 ± 12.79 mmHg, respec-
tively), but decreased at T40 and T60. This
was also observed by Skimming et al. (28) in
11 mechanically ventilated sheep with in-
duced acute pulmonary lesion, with the au-
thors concluding that P(a-et)CO2 was a good
predictor of VDalv. Similarly, Moreira et al.
(29), comparing two experimental situations,
i.e., PE and hemorrhagic shock, demonstrated
a significant increase of P(a-et)CO2 only in
PE, which was associated with increased
VDalv as measured by volumetric capnogra-
phy. The increase in P(a-et)CO2 was signifi-
cant and sufficiently specific to suggest the
diagnosis of PE.
Based on our data obtained in animals
under mechanical ventilation and submitted
to pulmonary embolism by injection of auto-
logous clots, we conclude that the severe
arterial hypoxemia observed must be attrib-
uted to the reduction of both VAeff and the
VAeff/Q ratio. These variables, as well as the
arterial hypoxemia, tended to recover with
time, but did not return to baseline levels
even after 60 min of embolism. This behav-
ior is attributed to the redistribution of the
alveolar ventilation induced by hypocapnic
bronchoconstriction.
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